Adam Koppel, M.D., Ph.D.
Adam Koppel, M.D., Ph.D. has served as a member of PTC's board of directors since March 2013. Since May 2014, Dr. Koppel has served as Senior Vice President and Chief Strategy Officer of Biogen Idec, where he is responsible for leading corporate strategy and portfolio management. Dr. Koppel previously was a Managing Director of Brookside Capital, the public equity affiliate of Bain Capital. Prior to Brookside Capital, he served as Associate Principal with McKinsey & Company where he consulted to companies in the pharmaceutical and biotechnology industries. Dr.Koppel also serves on the board of directors of Trevena, Inc. Dr. Koppel received an M.D. and Ph.D. from the University of Pennsylvania School of Medicine, an M.B.A. from the Wharton School of the University of Pennsylvania and a B.A. from Harvard University.